Form 4: Inspire Medical Systems Director Jerry C. Griffin Reports Stock Transactions

Director Jerry C. Griffin of Inspire Medical Systems, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 25, 2024, Jerry C. Griffin, a director of Inspire Medical Systems, Inc., executed transactions involving the company's common stock.
• Griffin exercised a stock option to acquire 1,000 shares at a price of $16 per share.
• Concurrently, Griffin sold 54 shares at $197.81 per share and 500 shares at $197.81 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 30, 2023.
• Following these transactions, Griffin directly owns 10,636 shares of Inspire Medical Systems, Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by a company director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions. It doesn't necessarily reflect a change in the company's outlook, but rather the execution of a pre-planned trading strategy by a company director.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's stock sales, but the pre-planned nature of the sales mitigates concerns about insider information.

Key Dates